At the end of September, Veritone (NASDAQ:VERI) has been accused by the short-selling advisory firm Citron of not being a real artificial intelligence enterprise, which brought its stock nearly to its all-time low. Since that time Veritone shares have been trading in a depressed territory, as the latest earnings report showed that the company continues to miss analysts revenue estimates, its earnings per share are in a negative territory and the increased expenses make it hard for the business to deliver earnings growth.
In addition, Veritone became a public company only in May, but in this short span of time, it already issued additional 800k shares of its common stock to fund its latest acquisitions, while its net loss has dramatically widened since that time.
Unlike the majority of other companies, Veritone couldnt be valued using traditional valuation tools like the discounted cash flow model since the company doesnt make any profit. Thereby, to understand how financially unhealthy Veritone is at the moment, we got the companys data from the Capital IQ platform and created a comparable analysis based on the past performance of the business. The table below shows that Veritone has negative multiples, while the overall industry is thriving. Also, its revenue is too small in comparison with others and the company burns its cash in the operational stages of its business development process, leaving no room to score any profit. Because of that, we couldnt possibly calculate the multiples for its EV/EBITDA and EV/EBIT. While we could say that Veritone is still in a late startup stage, its current market price is still too high in our opinion.
Top Growth Stocks For 2019: WPX Energy, Inc.(WPX)
- [By Money Morning News Team]
WPX Energy Inc. (NYSE: WPX) is a natural gas and oil company based in Oklahoma. WPX focuses on the exploration and development of natural gas and oil fields in North America, including the Permian Basin in Texas and the Williston Basin in North Dakota.
- [By Ezra Schwarzbaum]
Matador has grown its reserves throughout the commodity cycle, as well as its production and cash flow. Haas also likes the company’s history of identifying and acquiring acreage early and cheaply. Much of the analyst’s positive outlook is derived from Matador’s successful monetization of midstream assets and pattern of reinvestment.
WPX Energy Inc (NYSE: WPX), $18 Price Target
Haas praised WPX’s production base, which is “well balanced” between three major basins, and its production mix of 51 percent oil, 13 percent natural gas liquids and 36 percent natural gas.
Top Growth Stocks For 2019: DSP Group Inc.(DSPG)
- [By Lisa Levin]
Technology shares rose by 2 percent in the US market on Friday. Top gainers in the sector included Fabrinet (NYSE: FN), and DSP Group, Inc. (NASDAQ: DSPG).
Top Growth Stocks For 2019: Bed Bath & Beyond Inc.(BBBY)
- [By Peter Graham]
Mid caphomed茅cor retailer Bed Bath & Beyond Inc (NASDAQ: BBBY) reportedfiscal Q2 2017 earnings after the market closed on Tuesday with shares falling in the low double digits as results were far below expectations on restructuring and hurricane-related issues. Net sales decreased approximately 1.7% to $2.9 billion as comparable sales decreased by approximately 2.6% (primarily due to a 2.6% decrease in comp sales, partially offset by an increase of 0.9% in non-comp sales).Comparable sales from customer-facing digital channels continued to have strong growth in excess of 20% for the 13th consecutive quarter, while comparable sales from stores declined in the mid-single-digit percentage range during the fiscal 2017 second quarter. Net earningswere $.67 per diluted share ($94.2 million), including the unfavorable impacts of approximately $.08 per diluted share of cash restructuring charges associated with the acceleration of the realignment of store management structure announced on August 3, 2017; the estimated costs associated with the impact of Hurricane Harvey of approximately $.02 per diluted share; and the impact of the new share-based payment accounting standard of approximately $.01 per diluted share, versus $1.11 per diluted share ($167.3 million) for the fiscal 2016 second quarter.
- [By Ben Levisohn]
L Brands surged 11% to $47.85 today, while the S&P 500 rose 0.2% to2,357.49. And while L Brands was the best performer, retailers made up half of the 10 best performing stocks in the benchmark today: Nordstrom (JWN) advanced 2.9% to $44.71, Gap (GPS) jumped 5.1% to $24.06, Kohl’s (KSS) climbed 5.6% to $39.60, andBed Bath & Beyond (BBBY), which reported earnings last night, gained 3.4% to $39.08.
- [By Chris Lange]
The Bed Bath & Beyond Inc. (NASDAQ: BBBY) fiscal second-quarter results are scheduled after the close on Tuesday. The consensus earnings estimate is $0.95 per share, on $3.01 billion in revenue. The shares closed the week at $28.67. The consensus price target is $32.16, and the 52-week trading range is $26.96 to $48.83.
- [By Lisa Levin] Gainers
Trevena Inc (NASDAQ: TRVN) rose 10.8 percent to $3.60 in pre-market trading after dropping 4.97 percent on Wednesday.
Yum China Holdings Inc (NYSE: YUMC) rose 10.2 percent to $31.05 in pre-market trading after the company reported upbeat earnings for its first quarter.
Seres Therapeutics Inc (NASDAQ: MCRB) rose 9.1 percent to $11.39 in pre-market trading after dropping 5.26 percent on Wednesday.
Plug Power Inc (NASDAQ: PLUG) rose 8.9 percent to $2.45 in pre-market trading after surging 73.08 percent on Wednesday.
Coach Inc (NYSE: COH) rose 6.7 percent to $41.98 in pre-market trading. Coach named Ian Bickley as President, Global Business Development and Strategic Alliances.
Sapiens International Corporation N.V. (NASDAQ: SPNS) shares rose 6.1 percent to $13.91 in pre-market trading after gaining 0.54 percent on Wednesday.
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) rose 6.1 percent to $149.15 in pre-market trading. Jazz Pharma reached a settlement with Hikma Pharma related to Xyrem patent case. Mizuho downgraded Jazz from Buy to Neutral.
Interactive Brokers Group, Inc. (NASDAQ: IBKR) shares rose 6 percent to $36.72 in pre-market trading after declining 0.03 percent on Wednesday.
Rewalk Robotics Ltd (NASDAQ: RWLK) rose 5.3 percent to $2.00 in pre-market trading after the company disclosed that the U.S. Department of Veterans Affairs purchased 28 added Exoskeleton Systems.
Merrimack Pharmaceuticals Inc (NASDAQ: MACK) rose 5.1 percent to $3.29 in pre-market trading. Merrimack declared a $1.06 special dividend.
BioTime, Inc. (NYSE: BTX) shares rose 4.8 percent to $3.50 in pre-market trading. BioTime, reported the formation of new subsidiary AgeX Therapeutics, Inc.
Akari Therapeutics PLC (ADR) (NASDAQ: AKTX) shares rose 4.8 percent to $12.26 in pre-market trading after gaining 0.69 percent on Wednesday.
Bed Bath & Beyond Inc. (NASDAQ: BBBY) rose 3.6 percent to $39.15 in pre-market trading after the company posted better-than
- [By Casey Wilson]
At the same time Wal-Mart is taking away its price-match policy, other retailers are offering it for the first time. Target Corp. (NYSE: TGT), Bed Bath & Beyond Inc. (Nasdaq: BBBY), and Best Buy Co. Inc. (NYSE: BBY) all offer price-match guarantees on their merchandise.
- [By Trey Thoelcke]
Bed Bath & Beyond Inc. (NASDAQ: BBBY) is scheduled to report its fiscal third-quarter results after trading ends on Wednesday. The consensus analyst estimates are $0.99 in EPS and revenue of $3.01 billion. Shares ended trading on Friday at $47.27. The consensus price target is $42.76. The 52-week range is $38.60 to $52.71.